Health
Two repurposed drugs and a blue dye show potential as SARS-CoV-2 entry inhibitors – News-Medical.Net
A new multidisciplinary study from Australia, published in the open-access journal mBio, shows that three compounds used to treat cystic fibrosis, dry eye, and…
A new multidisciplinary study from Australia, published in the open-access journal mBio, shows that three compounds used to treat cystic fibrosis, dry eye, and a specific medical dye may lead to future strategies for the treatment of coronavirus disease (COVID-19).
The ongoing pandemic of COVID-19, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents a health emergency that necessitates the continued use of vaccines, but also the development of new drugs to prevent…
-
General16 hours agoStar Wars’ fascist dystopia has never felt closer than in new season of Andor
-
General19 hours agoCoalition to chart path forward as family feud cooled
-
Noosa News19 hours agoInterest rates: Why we will keep paying the same repayments
-
Noosa News16 hours agoQueensland Premier David Crisafulli keeps clear of Coalition chaos in Canberra